2011 SABCS Public All Photos
Read More
San Antonio, TX - SABCS 2011 San Antonio Breast Cancer Symposium: Jose Baselga MD, PhD discusses S5-5. A phase III, randomized, double-blind, placebo-controlled registration trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel vs. placebo + trastuzumab + docetaxel in patients with previously untreated HER2-positive metastatic breast cancer (CLEOPATRA) during the General Session 5 at the 2011 San Antonio Breast Cancer Symposium here today, Friday December 9, 2011. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Friday December 9, 2011 Photo by © SABCS/Todd Buchanan 2011 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
